Central Drugs Standard Control Organization

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India

Circulars

S.no Title Release Date Download Pdf Pdf Size
1 Regulatory guidelines for sampling of drugs cosmetics and medical devices by Drugs Inspectors of Central and State Drug Authorities 2024-Feb-09 1016 KB
2 Income Tax savings for FY- 2023-2024 2024-Feb-05 240 KB
3 Office Order regarding senitization programme on PoSH (Prevention of Sexual Harassment) 2024-Jan-16 1033 KB
4 Submission of Information of Immovable Property Return for the year 2023 through e-HRMS 2.0 in respect of all employees of CDSCO(HQ) Zone Sub-Zone Lab and Port Offices 2024-Jan-03 406 KB
5 Submission information of Immovable Property Return for the year 2023 in respect of Group-A & Group-B Gazetted and Group-B & Group-C Non-Gazetted (Ministerial and Non-Ministerial) Officers of CDSCO HQ and Zone Sub-Zone Lab and Ports Offices 2023-Dec-19 787 KB
6 Participation in National Programme for Civil Services Capacity Building (NPCSCB) Mission Karmayogi launched by the Government to promote role based capacity building of Civil Servants with the goal of offering a wide range of learning resources n the IGOT Karmayogi platform to enhance the knowledge skills and attitude of officials 2023-Dec-13 427 KB
7 Hospitality facility in respect of the officers of CDSCO Directorate General of Health Services 2023-Dec-07 388 KB
8 Participation in National Programme for Civil Services Capacity Building (NPCSCB) – Mission Karmayogi launched by the Government to promote role based capacity building of Civil Servants with the goal of offering a wide range of learning resources n the IGOT Karmayogi platform to enhance the knowledge skills and attitude of officials 2023-Nov-22 3069 KB
9 Circular Regarding Implement e-HRMS 2.0 Portal dated 16.11.2023 2023-Nov-16 259 KB
10 Circular regarding online applicatioin for Post Approval Changes (PAC) w.r.t Marketing Authorization (MA) for Human Vaccines and Anti-sera 2023-Nov-10 678 KB
11 Corrigendum to Notice inviting Expression of Interest for development of Digital Drugs Regulatory System 2023-Nov-10 434 KB
12 Circular for PAC Online Applications for Clinical Trial of Vaccine 2023-Oct-26
13 Reconstitution of Internal Complaint Committee on Sexual Harassment HQ 2023-Oct-18 459 KB
14 Regulation of all Class C & D Medical Devices Under Licensing regime, w.e,f 01.10.2023 as per GSR102E dated 11.02.2020 2023-Oct-12 385 KB
15 Reconstitution of Internal Complaint Committee on Sexual Harassment Mumbai West Zone 2023-Oct-09 178 KB
16 Reconstitution of Internal Complaint Committee on Sexual Harassment 2023-Sep-29 124 KB
17 Request for furnishing the details for timely generation of APARs on Sparrow portal through e-mail at apar.cdsco@gmail.com 2023-Sep-20 302 kb
18 Hon'ble Supreme Court in Civil Apeal NO. 2482 of 2014 forwarded by Ministry of Health and Family Welfare, an Internal Complaints Committee (ICC) as per provision of PoSH Act has already been formed by CDSCO(HQ) 2023-Sep-20 80808 KB
19 Approval of NABL Accredited Private Testing Laboratory for Testing of Cough Syrup to be exported by the Manufacturer/Exporter 2023-Sep-13 2263 KB
20 Calculation of lncome Tax for the Financial Year 2O23-24 2023-Sep-11 392 KB
21 Reconstitution of Internal Complaint Committee on Sexual Harassment CDTL Kolkata 2023-Sep-04 248 KB
22 Reconstitution of Internal Complaint Committee on Sexual Harassment North Zone 2023-Sep-04 160 KB
23 Reconstitution of Internal Complaint Committee on Sexual Harassment Hyderabad 2023-Sep-04 77 KB
24 Reconstitution of Internal Complaint Committee on Sexual Harassment Chennai 2023-Sep-04 57 KB
25 Reconstitution of Internal Complaint Committee on Sexual Harassment CDTL Mumbai 2023-Sep-04 318 KB
26 Reconstitution of Internal Complaint Committee on Sexual Harassment CDTL Kasauli 2023-Sep-04 591 KB
27 Reconstitution of Internal Complaint Committee on Sexual Harassment CDTL Hyderabad 2023-Sep-04 396 KB
28 Reconstitution of Internal Complaint Committee on Sexual Harassment CDTL Chennai 2023-Sep-04 41 KB
29 Azadi Ka Amrit Mahotsav AKAM HarGhar Tiranga Campaign 2023-Aug-11 10055 KB
30 Office Memorandam regarding appoint of CPIO for the purpose of RTI Technical matter 2023-Aug-01 313 KB
31 Online Application for the issuance of Form 11 (Test License) for Veterinary Vaccines /Drugs 2023-Jul-20 286 KB
32 Reconstitution of Internal Complaint Committee on Sexual Harassment dated 18.07.2023 2023-Jul-18 423 KB
33 Transfer Policy for the officers/officials of CDSCO dated 03.07.2023 2023-Jul-03 69 KB
34 Transfer order of DDC(I) dated 14.06.2023 2023-Jun-14 1066 KB
35 Daily Updation of No. of Batches of Cough syrup sample for Export at Different Laboratories for testing 2023-Jun-13 1224 KB
36 Circular for Licensing of Class C D medical devices 2023-Apr-12 310 KB
37 Rotational Tansfer of Officers of CDSCO 2023-Mar-21 247 KB
38 Office Memorandum regarding RTI Act 2005 for RDTL Chandigarh 2023-Mar-16 308 KB
39 Circular regarding submission of Immovable property Return for the year of 2022 2022-Dec-21 630 KB
40 Information Document on Suspension 2022-Nov-04 430 KB
41 Information Document on Prevention of Sexual Harassment of Women at Workplace 2022-Nov-04 478 KB
42 Circular regarding information document on pay fixation issued by Department of personnel and Training 2022-Sep-13 684 KB
43 Circular regarding Information document on increment issued by Department of personnel and Training 2022-Sep-12 624 KB
44 Transfer order for the year 2022-2023-4 2022-Sep-08 10353 KB
45 Har Ghar Tiranga Campaign 2022-Jul-13 812 KB
46 Transfer order for the year 2022-2023-2 2022-Jul-05 4607 KB
47 Office Memorandum regarding Sexual Harassment of Women at work Place constitution of a complaints committee 2022-Jun-17 856 KB
48 Modification of Instructions regarding Booking of Air Tickets on Government account 2022-Jun-16 1453 KB
49 Transfer order for the year 2022-2023 2022-May-04 4429 KB
50 Transfer order for the year 2022-2023-1 2022-Mar-10 1334 KB
51 Circular regarding filling up for the post of Junior Scientific Assistant CDTL Mumbai 2022-Jan-12 5011 KB
52 Circular regarding attendance dated 7 Jan 2022 2022-Jan-07 116 KB
53 Circulars dated 27 Oct 2021 regarding 2021-Oct-27 901 KB
54 Prior approval for Global Tender Enquiry under rule 161(Vi) of General Financial Rules (GFRs) 2021-Oct-14 1338 KB
55 Office Order regarding the Leaves(s) in respect of the officers of CDSCO 2021-Oct-12 432 KB
56 Special condition under which the permission for import of drug with residual shelf life less than 60% is allowed 2021-Sep-13 316 KB
57 Office order regarding leaves granted to Officers of CDSCO 2021-Aug-19 930 KB
58 Circular regarding Azadi Ka Amrit Mahotsav 2021-Aug-12 2039 KB
59 Circular regarding attending office during Parliament Session 2021-Aug-03 1880 KB
60 Data for Income Tax Calculation for the Financial Year 2021-22 2021-Aug-02 3990 KB
61 Clarification if change in a) Polymorphs/crystalline/amorphous/solvates/hydrate etc (b) salt and (c) Derivative/analogue/ester etc of already approved active substance to be considered as new drug if main active moiety (Active Pharmaceutical Ingredient-API) is same? 2021-Jul-23 131 KB
62 Consolidated Instructions for Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs), 2017 2021-Jul-07 3372 KB
63 Circular regarding attending office regularly dated 07.07.2021 2021-Jul-07 602 KB
64 Reconstituting of Internal Complaint Committee on sexual Harassment cases regarding 25 june 2021 2021-Jun-25 920 KB
65 Special Condition under which the permission for import of drug with residual shelf life less than 60% is allowed 2021-Apr-13 373 KB
66 RT-PCR Test for COVID-19 of the staff of CDSCO at FDA bhawan 2021-Apr-07 908 KB
67 Declaration of Holiday on 14th April 2021 Dr. B R Ambedkar 2021-Mar-31 334 KB
68 Office Meorandum regarding for pusuing higher qualification 2021-Mar-26 735 KB
69 Office Memorandum regarding submission of immovable property retrun for the year 2020 2021-Jan-05 1811 KB
70 Circulars dated 18 December 2020 2020-Dec-18 520 KB
71 Clarification regarding admissibility of Transport allowance druing Nation-Wide Lockdown due to COVID-19 pandemic 2020-Dec-08 328 KB
72 Clarification regarding reference standards 2020-Dec-04 260 KB
73 Submmission on Leave application in i-connect leave management System 2020-Oct-07 493 KB
74 circular regarding Special Condition under which the permission for import of drug with residual shelf life less than 60 % is allowed 2020-Jul-10 212 KB
75 Circular regarding Extension of validity of BA/BE Study Centres regarding 2020-Apr-30 344 KB
76 Circular regarding pocdure for lot release of Human vaccine in view of prevailing COVID-19 pandemic 2020-Apr-03 454 KB
77 Circular regarding exemption of biometric machine attendance till 31.03.2020 2020-Mar-06 857 KB
78 Circular regarding disposal of the application of WC for active substances exported to the Eu for medicinal products for Human use in accordance with Acrticle 42(2) 2020-Mar-04 664 KB
79 Circular regarding Disposal of the application of WHO-GMP 2020-Mar-03 617 KB
80 Circular Submission of certifice copy of APAR for consideration for Promotion confirmation grant of MACP etc to CDSCO HQ 2020-Feb-17 116 KB
81 Circular regarding Rational use of Antibiotics for limiting Antimicrobial resistance 2019-Dec-23 766 KB
82 Information/Guidance regarding uploading of manufacturing site and formulations data on SUGAM Portal 2019-Nov-29 384KB
83 Clarification on stability data requirement in case of CT and BABE study 2019-Oct-18 516 KB
84 Circular regarding clarification on stability data requirement in case of Clinical Trial and Bioavailability-Bioequivalance study 2019-Oct-18 668 KB
85 Circular regarding procedure for booking of air-tickets on LTC 2019-Sep-30 235 KB
86 Circulard dated 11 September 2019 2019-Sep-11 53 KB
87 Circular regarding WC dated 9.9.2019 2019-Sep-09 755 KB
88 Clarification on manufacturing of new drug by a manufacturer in their own multiple manufactring site 2019-Aug-30 89 KB
89 NOC for manufacture of Unapproved Banned New Drugs solely for Export purpose 2019-Aug-05 425 KB
90 Disposal of unserviceable/obsolete item of CDSCO 2018-Dec-21 322 KB
91 Pending Annual Performance Appraisal Report APARs of Drugs Inspectors in CDSCO regarding 2018-Sep-27 735 KB
92 Creation of Veterinary cell at CDSCO(HQ), New Delhi 2018-Jul-03 388KB
93 Gazette Notification of Drug Inspector 2018-Apr-12 1,680lb
94 Additional information regarding Medical Devices Rules 2017 2018-Mar-16 1,230kb
95 NSQ Vi-Conjugate Typhoid Vaccine Batch No.TC010915 and Batch No. TC010417 of M/s Bio Med Pvt Ltd 2018-Mar-14 904kb
96 Request to advice the manufacturers to submit stability data of non patent and proprietary medicines for grant of permission 2017-Aug-18 274kb
97 Circular Establishment of facilities for ther activities of coating assembling of components, sterilization etc for devices 2017-Aug-09 562kb
98 Clarification regarding submission of application for post approval changes of human Vaccines 2017-Jul-18 302kb
99 Testing of Sample of Imported Vaccine 2017-Jun-05 1,420kb
100 Acknowledgement for Level-III post approval changes Annual Notifications of biological products (vaccines &r-DNA) 2017-May-26 485kb
101 Delegation of Power to Sign Licence and Rigistration 2017-Apr-13 2920kb
102 Merit List based on the written examination held on 09.04.2017 at NIB Noida for WHO Roational Fellowhip Selection 2017-Apr-10 3,500kb
103 Circular regarding Human Vaccine 2017-Feb-16 50kb
104 Circular regarding first time import/manufacture in the country of Active Pharmaceutical Ingredient API of a drug which has earlier been approved as New Drug in Finished Formulation for import and marketing and /or allowed for import under import registration and Licensing 2016-Dec-30 396kb
105 Circular regarding NOC for export of biological products (Vaccine and r-DNA products) under Form 29 license to manufacture drugs for purposes of examination, test or analysis 2016-Dec-13 237kb
106 Circular regarding extension of Shelf Life within or up to the period of 60 Months for export purpose 2016-Oct-27 309kb
107 Circular regarding requirement of approval of Review Committee on Genetic Manipulation under Department of Biotechnology for r-DNA 2016-Aug-30 487kb
108 Circular regarding Requirement of NOC from DCGI for addition of new Clinical trial site or investigator 2016-Aug-03 493kb
109 Circular regarding Restriction of conducting three clinical trials per investigator 2016-Aug-02 243kb
110 Circular regarding Requirement of 50 bedded site for clinical trial 2016-Aug-02 258kb
111 Manufacturing and Marketing of Unapproval Drug, VitaminK2-7 2016-Jan-01 39kb
112 Pre-Screening work 2015-Dec-30 244kb
113 Requirement of approval of Review Committee on Generic Manipulation (RCGM) under Department of Biotechnology for r-DNA derived drugs like Insulin, Monoclonal antibody, etc 2015-Nov-10 242kb
114 Circular to all State/UT's Drugs Controller 2015-Aug-06 46kb
115 Draft Senority List of Assistant Drugs Inspectors CDSCO 2015-Jul-13 752kb
116 Draft Senority List of Drugs Inspectors CDSCO 2015-Jul-01 3,240kb
117 Circular regarding Import of Cosmetics 2015-Jun-29 428kb
118 2015-Jun-17 337kb
119 Availability of H1N1 Vaccine 2015-Feb-17 48kb
120 Exemption of Veterinary products from the purview of DCG(I) Letter 2015-Jan-15 361KB
121 Circular regarding written confirmation certificate 2014-Oct-22 92kb
122 Circular regarding strict regulatory control over the manufacture,sale and distribution of Oxytocin 2014-Oct-22 897kb
123 Minutes of Meeting 2014-Sep-08 22kb
124 Database of Fixed Dose Combinations (FDC's) Permitted for Manufacture for Sale in the Country 2014-Sep-05 574kb
125 Seventh Meeting of the Expert Committee on 29.08.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale in the country without due approval from office of DCG(I) 2014-Aug-29 262kb
126 Sixth Meeting of the Expert Committee on 27.08.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale in the country without due approval from office of DCG(I) 2014-Aug-27 274kb
127 Postponement of the Seventh Expert Committee Meeting from 29.08.2014 to 05.09.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale in the country without due approval from office of DCG(I) 2014-Aug-22 376kb
128 Specification and Criteria for Acceptance for test performed on blood glucose test strip and analyzer based glucose reagents 2014-Aug-07 359kb
129 Clarification on Form-29 for the Manufacture of Clinical Trial Material 2014-Jul-25 128kb
130 Circular 2014-Jul-17 306kb
131 Use of antibiotcs for Treatment of food producing animals and in animal feed 2014-Jun-06 286kb
132 Approval of the safety and efficacy of FDC permitted for manufacture for sale in the country without due approval form office of DCG(I) 2014-Jun-05 167kb
133 Third Meeting of the Expert Committee on 04.06.2014 to examine the matters related to approval of the safety and efficacy of FDC permitted for manufacture for sale in the country without due approval from office of DCG(I) 2014-May-26 170kb
134 Manufacture for sale in the country without due approval from office of DCG(I) 2014-May-26 174kb
135 Fourth Meeting of the Expert Committee on 11.06.2014 to Examine the Matters Related to Approval of the safety and efficacy of FDC Permitted 2014-May-26 132kb
136 Second Meeting of the Expert Committee on 23.04.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale in the country without due approval from office of DCG(I) 2014-Apr-04 668kb
137 Approval of the safety and efficacy of FDCs 2014-Mar-28 311kb
138 Restriction on use of formulations of Tramadol, Tapentadol as well as FDCs containing Tramadol 2014-Feb-14 138kb
139 Cancellation of Permission of FDC of Olmesartan Medoxomil + Amlodipine + Hydrochlorothiazide tablets 2014-Feb-07 441kb
140 Circular Regarding Approval of Safety and Efficacy Marketed in the Country of FDC's Without Approval from DCG(I) 2014-Feb-03 322KB
141 Bringing details about Drug Import alert/restrictions imposed by regulatory authorities abroad 2014-Jan-28 504KB
142 Grant of Permission to Manufacture and Market FDC of Cefixime 200mg 2013-Nov-11 184KB
143 Grant of Permission to Manufacture and Market Certain FDC 2013-Nov-05 154kb
144 Grant of Permission to Manufacture and Market FDC of Ofloxacin 200mg 2013-Oct-17 147KB
145 Approval of the safety and efficacy of Fixed Dose Combinations(FDCs) permitted for manufacture for sale in country without due approval from office of DCG(I) 2013-Sep-02 866kb
146 Furnishing of information in respect of financial support, fees, honorarium, payments in kind etc to be paid to the investigator as per contract entered into by the sponsor with the investigator/ insititution in clinical trials 2013-Aug-30 310kb
147 Approval of the safety and efficacy of FDCs permitted for manufacture for sale in country without due approval form office of DCG(I) 2013-Aug-26 567kb
148 Circular dated 05.07.2013 regarding approval of the safety and efficacy of Fixed Dose Combinations (FDCs) permitted for manufacture for sale in the country without due approval from office of DCG(I) 2013-Jul-05 912kb
149 Circular regarding drug import alert/ restrictions imposed by regulatory authorities abroad 2013-Jun-26 343kb
150 Circular regarding re-labeling/re-printing of revised prices as per NPPA's 2013-Jun-26 499kb
151 Sub -rule 3A of Rule 97 of drugs and cosmetics rules 1945 regarding withdrawal period 2013-May-23 244kb
152 Letter regarding safety and efficacy of FDCs permitted by State Licensing Authority without prior approval from DCG(I) 2013-Mar-21 288kb
153 Letter Approval of the safety and efficacy of Fixed Dose Combinations Permitted for manufacture for sale in the country without due approval form office of DCG(I) 2013-Jan-15 681kb
154 Letter Cancellation of permission/License in case an applicant/manufacturer fails to launch their product within a period of six month from obtaining the permission/license from CDSCO 2013-Jan-10 365kb
155 Letter To establish the safety and efficacy of the FDC of Flupenthixol+Melitracen on Indian population. 2013-Jan-10 400kb
156 General Information on antibiotics and antibiotic resistance. 2012-Dec-10 84kb
157 Order issued to CDSCO Zonal Offices on Special drive for assuring the quality of medicines. 2012-Dec-05 384kb
158 Letter on Important safety label changes to cholesterol lowering stating drug. 2012-Nov-06 1,030kb
159 Order regarding “Box Warning” on label/package insert of formulations containing Nimesulide. 2012-Apr-14 280kb
160 Clarification regarding Limiting of Acetaminophen (Paracetamol) in prescription combination products. 2012-Apr-04 329kb
161 Cosmetic NOC 2011-Nov-16 144kb
162 Circular regarding import of Cosmetic 2011-Nov-16 148kb
163 Letter regarding Limiting of Acetaminophen (Paracetamol) in Prescription Combination Products 2011-Sep-23 116kb
164 Letter regarding Phasing out of oral Single Drug Formulations of Artemisinin. 2011-Apr-25 110kb
165 Letter regarding Information for submission to Department related Parliament Standing Committee on H&FW 2011-Feb-03 62kb
166 Letter regarding Prohibition of manufacture and sale of Rosiglitazone. 2010-Nov-16 156kb
167 Letter regarding Suspension of import/manufacture of rosiglitazone in the country. 2010-Oct-07 101kb